Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9JANSSEN BIOTECH

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

ERDAFITINIB

US Patent Number : 11684620

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3806

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-09

blank

02

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

ERDAFITINIB

US Patent Number : 11684620

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3805

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-09

blank

03

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

ERDAFITINIB

US Patent Number : 11684620

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3807

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-09

blank

04

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

ERDAFITINIB

US Patent Number : 11684620

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3807

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-09

blank

05

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

ERDAFITINIB

US Patent Number : 11684620

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3806

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-09

blank

06

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

ERDAFITINIB

US Patent Number : 11684620

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3807

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-09

blank

07

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

ERDAFITINIB

US Patent Number : 11684620

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3805

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-09

blank

08

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

ERDAFITINIB

US Patent Number : 11684620

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3805

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-09

blank

09

arrow
BioProcess International
Not Confirmed
arrow
BioProcess International
Not Confirmed

ERDAFITINIB

US Patent Number : 11684620

Drug Substance Claim :

Drug Product Claim :

Application Number : 212018

Patent Use Code : U-3806

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2036-02-09

blank